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Heterozygous mutations in CTCF have been reported in patients with distinct clinical 
features including intellectual disability. However, the precise pathomechanism 
underlying the phenotype remains to be uncovered, partly because of the diverse 
function of CTCF. Here we describe extensive clinical and genetic investigation for two 
patients with a microdeletion encompassing CTCF. We performed genetic examination 
including comprehensive investigation of X chromosome inactivation and DNA 
methylation profiling at imprinted loci and genome-wide. Two patients showed 
comparable clinical features to those in a previous report, indicating that 
haploinsufficiency of CTCF was the major determinant of the microdeletion syndrome. 
Despite the haploinsufficiency of CTCF, X chromosome inactivation was normal. DNA 
methylation at imprinted loci was normal, but hypermethylation at CTCF binding sites 
was demonstrated, of which PRKCZ and FGFR2 were identified as candidate genes. 
This study confirms that haploinsufficiency of CTCF causes distinct clinical features, 
and that a microdeletion encompassing CTCF could cause a recognizable CTCF 
deletion syndrome. Perturbed DNA methylation at CTCF binding sites, not at imprinted 
loci, may underly the pathomechanism of the syndrome. 
 
